Rubius Therapeutics, Inc. | Business Contracts

Plan of Dissolution of Rubius Therapeutics, Inc (Filed With SEC on February 22, 2023)

Agreement for Termination of Lease, dated December 12, 2022, by and between Rubius Therapeutics, Inc. and ARE-MA Region No. 58, LLC (Filed With SEC on December 14, 2022)

Purchase and Sale Agreement, dated December 6, 2022, by and between Rubius Therapeutics, Inc. and DIV Acquisition V, LLC (Filed With SEC on December 12, 2022)

Non-Employee Director Compensation Policy dated February 24, 2021 (Filed With SEC on February 25, 2022)

Second Amendment to Loan and Security Agreement between Rubius Therapeutics, Inc. and SLR Investment Corp. (formerly Solar Capital Ltd.) dated June 22, 2021 (Filed With SEC on August 9, 2021)

Employment Agreement dated July 26, 2021 between Rubius Therapeutics, Inc. and Dannielle Appelhans (Filed With SEC on July 29, 2021)

Underwriting Agreement, dated March 16, 2021, among Rubius Therapeutics, Inc., J.P. Morgan Securities LLC, Jefferies LLC and Guggenheim Securities, LLC (Filed With SEC on March 18, 2021)

Employment Agreement dated September 23, 2020 between Rubius Therapeutics, Inc. and Jose Carmona (Filed With SEC on September 28, 2020)

Separation Agreement between Rubius Therapeutics, Inc. and Andrew M. Oh, dated June 29, 2020 (Filed With SEC on August 10, 2020)

Employment Agreement between Rubius Therapeutics, Inc. and Christina Coughlin, dated December 20, 2019 (Filed With SEC on May 11, 2020)

Employment Agreement between Rubius Therapeutics, Inc. and Laurence Turka, dated January 4, 2020 (Filed With SEC on May 11, 2020)

Description of Registrants Securities (Filed With SEC on March 12, 2020)

Employment Agreement between Rubius Therapeutics, Inc. and Maiken Keson-Brookes, dated October 7, 2019 (Filed With SEC on March 12, 2020)

First Amendment to the Loan and Security Agreement dated as of September 16, 2019 between Rubius Therapeutics, Inc. and Solar Capital Ltd (Filed With SEC on November 14, 2019)

Letter Agreement between Rubius Therapeutics, Inc. and Torben Straight Nissen, Ph.D. dated May 14, 2019 (Filed With SEC on August 13, 2019)

Second Amendment to the Exclusive Patent License Agreement between the Registrant and the Whitehead Institute for Biomedical Research, dated July 25, 2018 (Filed With SEC on March 28, 2019)

First Amendment to Lease Agreement between Rubius Therapeutics, Inc. and ARE-MA Region No. 58 LLC, dated November 8, 2018 (Filed With SEC on March 28, 2019)

Loan and Security Agreement between Rubius Therapeutics, Inc. and Solar Capital Ltd. dated December 21, 2018 (Filed With SEC on December 21, 2018)

Purchase and Sale Agreement between the Registrant and Alexion Pharmaceuticals, Inc., dated July 23, 2018 (Filed With SEC on July 25, 2018)

Form of Underwriting Agreement (Filed With SEC on July 9, 2018)

2018 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on July 9, 2018)

2018 Employee Stock Purchase Plan (Filed With SEC on July 9, 2018)

Employment Agreement between the Registrant and Pablo J. Cagnoni, M.D., dated July 2, 2018 (Filed With SEC on July 9, 2018)

Employment Agreement between the Registrant and Torben Straight Nissen, Ph.D., dated July 2, 2018 (Filed With SEC on July 9, 2018)

Employment Agreement between the Registrant and Andrew M. Oh, dated June 29, 2018 (Filed With SEC on July 9, 2018)

Employment Agreement between the Registrant and Christopher L. Carpenter, M.D., Ph.D., dated June 29, 2018 (Filed With SEC on July 9, 2018)

Second Amended and Restated Investors' Rights Agreement among the Registrant and certain of its stockholders, dated February 23, 2018 (Filed With SEC on June 22, 2018)

Amended and Restated Warrant to Purchase Stock, dated May 19, 2017, issued by the Registrant to PacWest Bancorp (Filed With SEC on June 22, 2018)

Amended and Restated Second Warrant to Purchase Stock, dated September 13, 2017, issued by the Registrant to PacWest Bancorp (Filed With SEC on June 22, 2018)

Amended and Restated 2014 Stock Incentive Plan, and form of award agreements thereunder (Filed With SEC on June 22, 2018)

Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 22, 2018)

Second Amended and Restated Chairman Agreement between the Registrant and David R. Epstein (Filed With SEC on June 22, 2018)

Rubius Therapeutics, Inc. (32)